Eli Lilly’s orforglipron cut body weight to a lesser extent than rival Novo Nordisk’s semaglutide, falling into analysts’ ...

According to the PCs, Winnipeg Fire Paramedic Service data shows a 25% decline in overdose-related calls and a 29% decrease in naloxone use since the organization’s previous drug injection RV was ...

Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or ...

US FDA announces new FDA PreCheck programme to boost US drug manufacturing: Silver Spring, Maryland Saturday, August 9, 2025, 12:00 Hrs [IST] The US Food and Drug Administration a ...

Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...

Key Points Surrozen reported GAAP EPS of $2.55 for Q2 2025, exceeding expectations by $3.66 per share (GAAP) due to significant one-time and non-cash gains. Surrozen recorded $1.0 million in research ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases ...

A new two-phase initiative aims to streamline facility approvals, reduce reliance on foreign pharmaceutical production, and ...

Pam Bondi announced a $50 million reward for the capture of Venezuelan president and alleged drug trafficker Nicolas Maduro.

Prince Harry is devastated by the perceived hostile takeover that pushed him out of Sentebale, the charity he co-founded.

FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatmentSignifi ...

In the fertile valleys of The Dalles, Oregon, an unsettling sight unfolds across Ian Chandler’s cherry orchards. Branches, once promising a vibrant harvest, now hang heavy with fruit described as ...